Jun. 9, 2025 at 10:04 AM ET6 min read

KNW Stock Skyrockets: Strategic Moves Behind the Surge

Tim BohenAvatar
Written by Tim Bohen
Reviewed by Ben Sturgill Fact-checked by Ellis Hobbs

Know Labs Inc. stock surged 103.79% following promising AI-based medical diagnostics results boosting investor confidence.

Market Buzz: What’s Fueling KNW’s Meteoric Rise?

  • Know Labs inks a critical agreement with Greg Kidd’s Goldeneye 1995 LLC, aiming for a Bitcoin-centric strategy by Q3 2025. The announcement spurs expectations of a shift in corporate dynamics, with Founder Erickson taking a new role.
  • Investor Greg Kidd’s decision to buy a controlling stake doubles Know Labs’ share value. His leadership commitment as CEO is seen as a potentially transformative move for the company.
  • KNW shares soar 155% on the major stake acquisition deal, signaling renewed investor confidence and potential growth with Kidd at the helm.
  • A dynamic investment strategy unfolds as Know Labs embraces Bitcoin treasury management, promising debt retirement and new infusion of 1,000 Bitcoin along with cash investments.
  • Legal challenges arise as Halper Sadeh LLC assesses the fairness of the Goldeneye merger, raising concerns about possible fiduciary duty breaches.

Candlestick Chart

Live Update At 10:04:26 EST: On Monday, June 09, 2025 Know Labs Inc. stock [NYSE American: KNW] is trending up by 103.79%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

A Closer Look at Know Labs Inc.’s Financial Performance

As Tim Bohen, lead trainer with StocksToTrade says, “Preparation is half the trade. By the time the bell rings, my decisions are nearly made.” Having a solid plan before engaging in the market is crucial for traders. A well-prepared trader will have already analyzed trends, evaluated risks, and set their strategies in place. This preparation allows them to act decisively and confidently during trading sessions, making the most of every opportunity that arises. Without preparation, trading can easily become a game of chance rather than a calculated endeavor.

The current developments at Know Labs paint an ambitious picture. Financially, the company faces hurdles, but recent strategic maneuvers might just change the game. Looking at their recent income statement, Know Labs recorded a substantial net loss from continuing operations. This loss stands at notably $3.58M, fueled largely by high operating and general expenses. The company’s current liabilities have ballooned to $6.83M, dwarfing the total assets, pegging the working capital at a stark deficit of $6.19M.

Interestingly, Know Labs holds aspirations to leverage their upcoming Bitcoin strategy. This decision hints at a risk-taking approach to transform existing economic strains into opportunities. While traditional revenue streams show contraction, the infusion of cryptocurrency could foster liquidity and spur investor interest.

More Breaking News

Their enterprise value sits at $57.71M, yet figures like negative return on assets and a fragile quick ratio of zero emphasize the need for bolstering their financial footing. Despite this, the recent raise in their share value, skyrocketing from mere cents to over $3.42, implies investor speculation about potential turnarounds and revitalized growth under Kidd’s guide.

The Power Behind Greg Kidd’s Stake

Goldeneye’s acquisition doesn’t just alter the logistics; it rearranges the narrative. Financial markets are often puzzles solved by unwritten stories. With Greg Kidd emerging as the prospective CEO and Chairman, there’s a palpable difference in the usual market rhythm. A fintech veteran, Kidd might not only provide capital but revitalize Know Labs with fintech innovation, potentially steering the company into greener pastures.

The blend of cryptocurrency with traditional stock strategies suggests an aggressive, novel path. The deal comes with Kidd’s promise to clear debts and refund operations, making investors curious and the company’s stock more appealing. It’s the combination of legacy repositioning and Kidd’s leadership that fuels excitement, as market emotions evolve into tangible stock price actions.

Legal Concerns: Shadows Over Enthusiasm

While optimism runs high, legal investigations hover over the transaction. Halper Sadeh’s scrutiny focuses on the fairness of the sale, critiquing whether fiduciary obligations were breached. The firm questions whether Goldeneye’s offer undercuts KNW’s value, resonating with investor sentiments wary of uninformed decisions.

Though legal wrangles could impose short-term volatilities, they indirectly expose and ensure accountability, potentially driving governance improvements as stakeholders push for transparency. This legal tension reflects the broader market challenge of balancing dramatic business pivots with shareholders’ interests.

Conclusion: Navigating Risks for Potential Rewards

As Know Labs embarks on this new voyage with Kidd at the wheel, traders are offered a glimpse into the paradoxes of innovation and risk. The stock’s recent climb symbolizes more than a financial gain; it echoes hopes of strategic renewal. Yet, as with any journey into the unknown, rewards are shadowed by potential pitfalls. As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.” The importance of this advice cannot be understated as Know Labs navigates its future. In the coming chapters for Know Labs, the stakes and strategies entwine, pushing KNW into a future yet unwritten. For those with the appetite for adventure, it’s a market tale of transformation waiting to unfold, one Bitcoin and business decision at a time. Will Know Labs continue its ascent under new stewardship, or will unforeseen market currents demand more from its sails? Only time will unravel this intriguing mix of risk and opportunity.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.